12:00 AM
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Other News

Virttu Biologics cancer news

Virttu launched its Virttu Replicate Open Innovation Forum to provide potential academic, biotech and pharma partners the opportunity to access its oncolytic virus seprehvir...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >